Antagomir- 17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM

Laura Fontana, Micol E. Fiori, Sonia Albini et al. · 2008

Read Antagomir- 17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM by Laura Fontana, Micol E. Fiori, Sonia Albini et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002236.txt.

Description

Laura Fontana, Micol Fiori, Sonia Albini, and co-authors blocked a small RNA to fight stubborn neuroblastoma, in a 2008 PLOS ONE paper. Neuroblastoma is a childhood cancer of nerve tissue, and some tumors resist therapy. The team had traced a key pathway: the cancer gene MYCN, when overactive, switches on a cluster of microRNAs that includes miR-17-5p.

Those microRNAs suppress two protective proteins, p21 and BIM, letting tumor cells grow unchecked. Blocking miR-17-5p with an antagomir, a molecule built to silence it, abolished the growth of therapy-resistant neuroblastoma in their tests. The result nominates one small RNA as a drug target in a hard cancer.

Catalog record

CREATORLaura Fontana, Micol E. Fiori, Sonia Albini et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002236

Browse the full library · About the Tower of Babel